Mann; Charles William

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mann; Charles William.The latest application filed is for "polar quinazolines".

Company Profile

0.6.17

Mann; Charles William - Plymouth Meeting PA
Mann; Charles William - Philadelphia PA
Mann; Charles William - North Wales PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polar Quinazolines App 20100184786 - Travins; Jeremy Mark ; et al.	2010-07-22
Quinoxaline-based Lxr Modulators App 20100120778 - Hu; Baihua ; et al.	2010-05-13
Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production App 20100120725 - Kreft; Anthony Frank ; et al.	2010-05-13
Gonadotropin releasing hormone receptor antagonists Grant 7,696,210 - Garrick , et al. April 13, 2	2010-04-13
Substituted phenylsulfonamide inhibitors of beta amyloid production Grant 7,671,075 - Kreft , et al. March 2, 2	2010-03-02
Aryl Sulfamide Derivatives And Methods Of Their Use App 20100029641 - McComas; Casey Cameron ; et al.	2010-02-04
Aryl sulfamide derivatives and methods of their use Grant 7,601,722 - McComas , et al. October 13, 2	2009-10-13
Trifluoromethyl-containing Phenylsulfonamide Beta Amyloid Inhibitors App 20090221711 - Porte; Alexander Michael ; et al.	2009-09-03
Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors Grant 7,550,629 - Porte , et al. June 23, 2	2009-06-23
Naphthylpyrimidine, Naphthylpyrazine And Naphthylpyridazine Analogs And Their Use As Agonists Of The Wnt-beta-catenin Cellular Messaging System App 20090054392 - Pelletier; Jeffrey Claude ; et al.	2009-02-26
Heteroaryl/aryl Pyrimidine Analogs And Their Use As Agonists Of The Wnt-beta-catenin Cellular Messaging System App 20080287452 - BURSAVICH; Matthew Gregory ; et al.	2008-11-20
Hydroxy-substituted Aryl Sulfamide Derivatives And Methods Of Their Use App 20080194654 - McComas; Casey Cameron ; et al.	2008-08-14
Cyclic Sulfonamide Derivatives And Methods Of Their Use App 20080171737 - Fensome; Andrew ; et al.	2008-07-17
Aryl Sulfamide Derivatives And Methods Of Their Use App 20080167303 - McComas; Casey Cameron ; et al.	2008-07-10
Aminoalkyl Substituted Aryl Sulfamide Derivatives And Methods Of Their Use App 20080161366 - McComas; Casey Cameron ; et al.	2008-07-03
Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors App 20070249722 - Porte; Alexander Michael ; et al.	2007-10-25
Substituted phenylsulfonamide inhibitors of beta amyloid production App 20070037778 - Kreft; Anthony Frank ; et al.	2007-02-15
Substituted phenylsulfonamide inhibitors of beta amyloid production Grant 7,166,622 - Kreft , et al. January 23, 2	2007-01-23
Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor App 20060264631 - Green; Daniel Michael ; et al.	2006-11-23
Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 Grant 7,101,855 - Dressen , et al. September 5, 2	2006-09-05
Gonadotropin releasing hormone receptor antagonists App 20060019965 - Garrick; Lloyd Michael ; et al.	2006-01-26
Substituted phenylsulfonamide inhibitors of beta amyloid production App 20040006050 - Kreft, Anthony Frank ; et al.	2004-01-08
Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 App 20030027771 - Dressen, Darren B. ; et al.	2003-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.